Gaucher's disease: investigations
Evidence-based neurology checklist on gaucher's disease: investigations: Biomarkers Angiotensin converting enzyme (ACE) Ferritin Tartrate-resistant acid phosphatase Chitotriosidase PARC/CCL18 LysoGL1 Screening Investigations
Biomarkers
- Angiotensin converting enzyme (ACE)
- Ferritin
- Tartrate-resistant acid phosphatase
- Chitotriosidase
- PARC/CCL18
- LysoGL1
Screening
Investigations
References
- Linari S, Castaman G. Clinical manifestations and management of Gaucher disease. Clin Cases Miner Bone Metab 2015; 12:157-164.
- Dumitrascu DL. Gaucher disease: an update. Med Pharm Rep 2021; 94(Suppl No 1):S54-S56.
- Roshan Lal T, Sidransky E. The spectrum of neurological manifestations associated with Gaucher disease. Diseases 2017; 5:10.